凯姆菲罗尔:揭示其抗炎性质,用于治疗创新
Tatiana Elizabeth Sánchez Herrera1, Iván Patricio Salgado Tello1, Mohammed Ahmed Mustafa2
1Facultad de Ciencias Pecuarias, Escuela Superior Politécnica de Chimborazo (ESPOCH), Riobamba 060106, Ecuador.
Cytokine
|January 4, 2025
概括
凯姆菲罗尔是一种天然的黄类化合物,通过减少炎症介质和氧化应激,显示出显著的抗炎作用. 需要进一步的研究,以克服在炎症性疾病中临床使用的生物可用性挑战.
科学领域:
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 炎症是许多急性和慢性疾病的关键因素.
- 正在探索自然存在的化合物作为替代抗炎治疗方法.
- 在植物中发现的黄醇 (kaempferol) 具有潜在的治疗性质.
研究的目的:
- 为了研究kaempferol的抗炎和抗氧化潜力.
- 阐明凯姆菲罗尔调节炎症通路的机制.
- 评估kaempferol在各种炎症疾病模型中的疗效.
主要方法:
- 在体外和体内生物研究的全面审查.
- 对凯姆菲罗尔对促炎性细胞因子和酶 (COX-2,iNOS) 的作用的分析.
- 研究凯姆菲罗尔对氧化应激通路 (Nrf2) 和信号通路 (NF-κB,MAPK,STAT) 的影响.
主要成果:
- 凯姆菲罗尔有效地抑制了关键的炎症媒介和细胞因子.
- 它通过Nrf2激活表现出抗氧化作用.
- 在败血症,神经退行性,心血管和自身免疫性疾病的模型中观察到保护作用.
- 证实了NF-κB,MAPK和STAT通路的调节.
结论:
- 凯姆菲罗尔作为一种天然的抗炎药物显示出显著的前景.
- 它能够准多个炎症和氧化应激途径是值得注意的.
- 生物可用性和稳定性的挑战需要进一步研究临床转化.
- 需要进行额外的临床研究来证实疗效和优化使用.
相关概念视频
Inflammatory Response
1.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K
Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Inflammatory Bowel Disease IV: Pharmacological Management
110
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
110


